Urinary Glycosaminoglycans as Biomarker for Urothelial Injury: Is It Possible to Discriminate Damage From Recovery? (2008)
- Autores:
- Autores USP: SROUGI, MIGUEL - FM ; CÂMARA, NIELS OLSEN SARAIVA - ICB
- Unidades: FM; ICB
- DOI: 10.1016/j.urology.2008.01.028
- Assuntos: BIOMARCADORES; GLICOSAMINOGLICANAS; URINA (ANÁLISE)
- Idioma: Inglês
- Imprenta:
- Fonte:
- Este periódico é de assinatura
- Este artigo NÃO é de acesso aberto
- Cor do Acesso Aberto: closed
-
ABNT
SOLER, Roberto et al. Urinary Glycosaminoglycans as Biomarker for Urothelial Injury: Is It Possible to Discriminate Damage From Recovery?. Urology, v. 72, n. 4, p. 937-942, 2008Tradução . . Disponível em: https://doi.org/10.1016/j.urology.2008.01.028. Acesso em: 10 maio 2024. -
APA
Soler, R., Bruschini, H., Martins, J. R., Dreyfuss, J. L., Câmara, N. O. S., Alves, M. T., et al. (2008). Urinary Glycosaminoglycans as Biomarker for Urothelial Injury: Is It Possible to Discriminate Damage From Recovery? Urology, 72( 4), 937-942. doi:10.1016/j.urology.2008.01.028 -
NLM
Soler R, Bruschini H, Martins JR, Dreyfuss JL, Câmara NOS, Alves MT, Leite KR, Truzzi JC, Nader HB, Srougi M, Ortiz V. Urinary Glycosaminoglycans as Biomarker for Urothelial Injury: Is It Possible to Discriminate Damage From Recovery? [Internet]. Urology. 2008 ; 72( 4): 937-942.[citado 2024 maio 10 ] Available from: https://doi.org/10.1016/j.urology.2008.01.028 -
Vancouver
Soler R, Bruschini H, Martins JR, Dreyfuss JL, Câmara NOS, Alves MT, Leite KR, Truzzi JC, Nader HB, Srougi M, Ortiz V. Urinary Glycosaminoglycans as Biomarker for Urothelial Injury: Is It Possible to Discriminate Damage From Recovery? [Internet]. Urology. 2008 ; 72( 4): 937-942.[citado 2024 maio 10 ] Available from: https://doi.org/10.1016/j.urology.2008.01.028 - Urinary glycosaminoglycans excretion and the effect of dimethyl sulfoxide in an experimental model of non-bacterial cystitis
- Pioglitazone limits cyclosporine nephrotoxicity in rats
- The role of toll-like receptor 4 in cisplatin-induced renal injury
- A role for HO-1 in the renal function impairment inrapamucin-treated animals submitted to ischemic and reperfusion injury (IRI)
- Renal transplantation outcomes: a comparative analysis between elderly and younger recipients
- High expression of Tim-3 mRNA in urinary cells from kidney transplant recipients with acute rejection
- Detection of Vbeta11 positive cells inside renal allograft during acute rejection
- PPARg agonists on renal ischemia/reperfusion injury
- Role of PPARy-activation in established chronic cyclosporine nephrotoxicity
- Mesenchymal stem cell therapy in remnant kidney fibrotic model does not improve long term renal outcome
Informações sobre o DOI: 10.1016/j.urology.2008.01.028 (Fonte: oaDOI API)
Como citar
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
